Marker for therapy response in acute myeloid leukemia identified

With the combination of the drugs Venetoclax and 5-Azacitidine, a new, effective and more tolerable alternative to chemotherapy for the treatment of AML has been available for several years. But for some patients, the drug combination does not work.

Leave A Comment

Your email address will not be published. Required fields are marked *